Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | VIR |
---|---|---|
09:32 ET | 54810 | 7.35 |
09:34 ET | 46920 | 7.65 |
09:36 ET | 15369 | 7.5796 |
09:38 ET | 51153 | 8.02 |
09:39 ET | 30167 | 8.05 |
09:41 ET | 29893 | 8.1396 |
09:43 ET | 52817 | 8.24 |
09:45 ET | 19805 | 8.22 |
09:48 ET | 39120 | 8.275 |
09:50 ET | 78040 | 8.585 |
09:52 ET | 71864 | 8.82 |
09:54 ET | 248404 | 8.98 |
09:56 ET | 224639 | 9.0133 |
09:57 ET | 132990 | 8.99 |
09:59 ET | 182773 | 9.24 |
10:01 ET | 107891 | 9.05 |
10:03 ET | 198406 | 9.26 |
10:06 ET | 109827 | 9.4084 |
10:08 ET | 220567 | 9.699 |
10:10 ET | 127090 | 9.56 |
10:12 ET | 100714 | 9.62 |
10:14 ET | 123261 | 9.487 |
10:15 ET | 104329 | 9.375 |
10:17 ET | 120519 | 9.06 |
10:19 ET | 88502 | 9.07 |
10:21 ET | 122120 | 8.705 |
10:24 ET | 126252 | 8.78 |
10:26 ET | 101627 | 8.8468 |
10:28 ET | 91327 | 8.79 |
10:30 ET | 72367 | 8.757 |
10:32 ET | 73209 | 8.71 |
10:33 ET | 76447 | 8.5231 |
10:35 ET | 57379 | 8.6141 |
10:37 ET | 31113 | 8.651 |
10:39 ET | 11487 | 8.605 |
10:42 ET | 15302 | 8.535 |
10:44 ET | 25380 | 8.43 |
10:46 ET | 104878 | 8.529 |
10:48 ET | 10754 | 8.49 |
10:50 ET | 6174 | 8.42 |
10:51 ET | 14112 | 8.48 |
10:53 ET | 14740 | 8.465 |
10:55 ET | 10939 | 8.479588 |
10:57 ET | 45339 | 8.7245 |
11:00 ET | 31346 | 8.66 |
11:02 ET | 17722 | 8.7 |
11:04 ET | 11504 | 8.7 |
11:06 ET | 13787 | 8.73 |
11:08 ET | 10463 | 8.73 |
11:09 ET | 12410 | 8.725 |
11:11 ET | 3261 | 8.72 |
11:13 ET | 6929 | 8.82 |
11:15 ET | 10188 | 8.85 |
11:18 ET | 18439 | 8.89 |
11:20 ET | 13236 | 8.83 |
11:22 ET | 9572 | 8.85 |
11:24 ET | 4846 | 8.889 |
11:26 ET | 10932 | 8.88 |
11:27 ET | 37102 | 8.9 |
11:29 ET | 9639 | 8.8754 |
11:31 ET | 85168 | 8.94 |
11:33 ET | 30515 | 8.83 |
11:36 ET | 11706 | 8.84 |
11:38 ET | 15354 | 8.9 |
11:40 ET | 32348 | 8.92 |
11:42 ET | 6056 | 8.885 |
11:44 ET | 6294 | 8.93 |
11:45 ET | 5905 | 8.865 |
11:47 ET | 5771 | 8.88 |
11:49 ET | 21301 | 8.89 |
11:51 ET | 7654 | 8.94 |
11:54 ET | 7900 | 8.895 |
11:56 ET | 6099 | 8.875 |
11:58 ET | 25998 | 8.8608 |
12:00 ET | 7829 | 8.89 |
12:02 ET | 18944 | 9.009129 |
12:03 ET | 30449 | 8.97 |
12:05 ET | 8126 | 8.995 |
12:07 ET | 2156 | 8.98 |
12:09 ET | 5274 | 8.95 |
12:12 ET | 5426 | 8.975 |
12:14 ET | 7564 | 8.9598 |
12:16 ET | 1395 | 8.9667 |
12:18 ET | 1510 | 8.97 |
12:20 ET | 7858 | 8.97 |
12:21 ET | 4352 | 8.945 |
12:23 ET | 11462 | 8.96 |
12:25 ET | 13357 | 8.94 |
12:27 ET | 8137 | 8.975 |
12:30 ET | 2739 | 8.96 |
12:32 ET | 9182 | 8.99 |
12:34 ET | 3050 | 9.03 |
12:36 ET | 2561 | 9.045 |
12:38 ET | 2815 | 9.07 |
12:39 ET | 10022 | 9.11 |
12:41 ET | 8063 | 9.12 |
12:43 ET | 44668 | 9.17 |
12:45 ET | 27586 | 9.0857 |
12:48 ET | 6986 | 9.055 |
12:50 ET | 8334 | 9.1101 |
12:52 ET | 5501 | 9.1287 |
12:54 ET | 2479 | 9.14 |
12:56 ET | 27735 | 9.185 |
12:57 ET | 28561 | 9.1748 |
12:59 ET | 5139 | 9.14 |
01:01 ET | 10858 | 9.24 |
01:03 ET | 7003 | 9.14 |
01:06 ET | 20028 | 9.05 |
01:08 ET | 7397 | 9.1 |
01:10 ET | 6382 | 9.1118 |
01:12 ET | 7410 | 9.18 |
01:14 ET | 2571 | 9.17 |
01:15 ET | 5133 | 9.19 |
01:17 ET | 6773 | 9.21 |
01:19 ET | 6355 | 9.22 |
01:21 ET | 4061 | 9.19 |
01:24 ET | 4534 | 9.185 |
01:26 ET | 1136 | 9.2 |
01:28 ET | 18588 | 9.2 |
01:30 ET | 3564 | 9.24 |
01:32 ET | 22311 | 9.23 |
01:33 ET | 23719 | 9.25 |
01:35 ET | 16709 | 9.21 |
01:37 ET | 8922 | 9.21 |
01:39 ET | 7784 | 9.21 |
01:42 ET | 4298 | 9.2 |
01:44 ET | 11541 | 9.195 |
01:46 ET | 13581 | 9.19 |
01:48 ET | 1919 | 9.1924 |
01:50 ET | 1771 | 9.19 |
01:51 ET | 5788 | 9.21 |
01:53 ET | 3468 | 9.19 |
01:55 ET | 10034 | 9.19 |
01:57 ET | 1949 | 9.19 |
02:00 ET | 7344 | 9.2 |
02:02 ET | 11199 | 9.215 |
02:04 ET | 8079 | 9.205 |
02:06 ET | 10087 | 9.185 |
02:08 ET | 4763 | 9.165 |
02:09 ET | 16050 | 9.1854 |
02:11 ET | 5833 | 9.21 |
02:13 ET | 3735 | 9.215 |
02:15 ET | 5396 | 9.18 |
02:18 ET | 6729 | 9.2 |
02:20 ET | 3457 | 9.21 |
02:22 ET | 3170 | 9.235 |
02:24 ET | 3173 | 9.225 |
02:26 ET | 40253 | 9.2301 |
02:27 ET | 4505 | 9.23 |
02:29 ET | 3097 | 9.25 |
02:31 ET | 3561 | 9.23 |
02:33 ET | 3192 | 9.24 |
02:36 ET | 5703 | 9.26 |
02:38 ET | 21180 | 9.29 |
02:40 ET | 3636 | 9.29 |
02:42 ET | 6215 | 9.31 |
02:44 ET | 16349 | 9.32 |
02:45 ET | 6002 | 9.315 |
02:47 ET | 20920 | 9.325 |
02:49 ET | 3328 | 9.34 |
02:51 ET | 16558 | 9.31 |
02:54 ET | 6339 | 9.32 |
02:56 ET | 7477 | 9.3112 |
02:58 ET | 6254 | 9.3123 |
03:00 ET | 39622 | 9.315 |
03:02 ET | 8168 | 9.27 |
03:03 ET | 3443 | 9.275 |
03:05 ET | 10908 | 9.29 |
03:07 ET | 4538 | 9.295 |
03:09 ET | 10231 | 9.25 |
03:12 ET | 5804 | 9.24 |
03:14 ET | 10391 | 9.215 |
03:16 ET | 13271 | 9.22 |
03:18 ET | 12274 | 9.26 |
03:20 ET | 10969 | 9.25 |
03:21 ET | 12243 | 9.275 |
03:23 ET | 9987 | 9.27 |
03:25 ET | 6778 | 9.255 |
03:27 ET | 17152 | 9.275 |
03:30 ET | 24372 | 9.265 |
03:32 ET | 34216 | 9.265 |
03:34 ET | 14479 | 9.22 |
03:36 ET | 12979 | 9.175 |
03:38 ET | 7652 | 9.185 |
03:39 ET | 11928 | 9.22 |
03:41 ET | 10844 | 9.19 |
03:43 ET | 7464 | 9.16 |
03:45 ET | 10872 | 9.16 |
03:48 ET | 14571 | 9.175 |
03:50 ET | 15225 | 9.2099 |
03:52 ET | 36775 | 9.21 |
03:54 ET | 33164 | 9.21 |
03:56 ET | 42898 | 9.215 |
03:57 ET | 88934 | 9.27 |
03:59 ET | 468564 | 9.26 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Vir Biotechnology Inc | 1.0B | -2.6x | --- |
Zymeworks Inc | 973.3M | -8.7x | --- |
Prothena Corporation PLC | 914.3M | -16.5x | --- |
Arcutis Biotherapeutics Inc | 971.4M | -4.0x | --- |
Silence Therapeutics PLC | 807.2M | -14.2x | --- |
Silence Therapeutics PLC | 807.2M | -13.2x | --- |
Vir Biotechnology, Inc. is an immunology company, which is focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions. The Company's clinical development pipeline consists of product candidates targeting hepatitis delta virus (HDV), hepatitis B virus (HBV), and human immunodeficiency virus (HIV). It also has several preclinical candidates in its pipeline including those targeting influenza A and B, COVID-19, respiratory syncytial virus and human metapneumovirus (RSV and MPV), and human papillomavirus (HPV). The Company's pipeline includes VIR-1949, VIR-7229, VIR-2981, VIR-8190, and HIV Cure. It also engaged in developing tobevibart, a monoclonal antibody also known as VIR-3434, and Elebsiran, an siRNA also known as VIR-2218, for the treatment and suppression of chronic HDV. Its Elebsiran is an investigational HBV-targeted siRNA that reduces HBsAg, a protein which is required for the HDV viral life cycle.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.0B |
---|---|
Revenue (TTM) | $78.9M |
Shares Outstanding | 136.6M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.46 |
EPS | $-3.58 |
Book Value | $11.80 |
P/E Ratio | -2.6x |
Price/Sales (TTM) | 13.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -715.62% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.